Application of Ulex europaeus agglutinin I-modified liposomes for oral vaccine: Ex vivo bioadhesion and in Vivo immunity

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 5, 2011, Pages 618-623

  Li, KeXin ^a   Zhao, XiuLi ^a   Xu, ShiYi ^a   Pang, DaHai ^b   Yang, ChunRong ^a   Chen, DaWei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Shenyang Food and Drug Administration   (China)

Author keywords

Liposome; Mucosal immune response; Oral immunization; Systemic immune response; Ulex europaeus agglutinin I

Indexed keywords

BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPOSOME; ULEX EUROPAEUS AGGLUTININ; ULEX EUROPAEUS AGGLUTININ I; UNCLASSIFIED DRUG; VACCINE;

ADHESION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; EX VIVO STUDY; FEMALE; GASTROINTESTINAL MUCOSA; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; MOUSE; NONHUMAN;

ADMINISTRATION, ORAL; ANIMALS; CELL ADHESION; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; INTESTINAL MUCOSA; LIPOSOMES; MICE; MICE, INBRED STRAINS; PLANT LECTINS; SERUM ALBUMIN, BOVINE; VACCINATION; VACCINES;

EID: 79955613203     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.618     Document Type: Article

References (19)

1. Sah H., Chien Y. W., J. Pharm. Pharmacol., 48, 32-36 (1996).
2. Rajananthanan P., Attard G. S., Sheikh N. A., Vaccine, 17, 715-730 (1999).
3. Minato S., Iwanaga K., Kakemi M., Yamashita S., Oku N., J. Controlled Release, 89, 189-197 (2003).
4. Trollé S., Andremont A., Fattal E., STP Pharm. Sci., 8, 19-30 (1998).
5. Lavelle E. C., Grant G., Pfuller U., J. Drug Target, 12, 89-95 (2004).
6. Lavelle E. C., Methods, 38, 84-89 (2006).
7. Gabor F., Bogner E., Weissenboeck A., Adv. Drug Deliv. Rev., 56, 459-480 (2004).
8. Anne des R., Virginie F., J. Controlled Release, 116, 1-27 (2006).
9. Alves A. C., Ramaldes G. A., Cell. Immunol., 254, 63-73 (2008).
10. Dinesh M., Pradyumna K. M., Eur. J. Pharm. Sci., 33, 424-433 (2008).
11. Bies C., Lehr C. M., Woodley J. F., Adv. Drug Deliv. Rev., 56, 425-435 (2004).
12. Keegan M. E., Royce S. M., Fahmy T., J. Controlled Release, 110, 574-580 (2006).
13. Dai C. Y., Wang B. C., Zhao H. W., Li B., Colloid Surfaces B Biointerfaces, 42, 253-258 (2005).
14. Weissenboeck A., Bogner E., Wirth M., Pharm. Res., 21, 1917-1923 (2004).
15. Ezpeleta I., Arangoa M. A., Irache J. M., Stainmesse S., Chabenat C., Popineau Y., Orecchioni A. M., Int. J. Pharm., 191, 25-32 (1999).
16. Bendas G., Krause A., Bakowsky U., Vogel J., Int. J. Pharm., 181, 79-93 (1999).
17. Liu X., Chen D. W., Xie L. P., Zhang R. Q., J. Controlled Release, 93, 293-300 (2003).
18. Irie T., Watarai S., Kodama H., Dev. Comp. Immunol., 27, 413-421 (2003).
19. Brophy M. R., Deasy P. B., Int. J. Pharm., 37, 41-47 (1987).